Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Ceva Santé Animale acquires Scout Bio, paving the way for groundbreaking innovations in pet therapeutics
2024-01-26 06:00
First International Shipment of HANSIZHUANG Launched
2024-01-25 21:41
Esaote unveils its new brand identity at 2024 Worldwide Sales & Marketing Meeting, Florence
2024-01-25 21:00
First International Shipment of HANSIZHUANG
2024-01-25 20:45
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
2024-01-25 18:38
Glenmark, Jiangsu Alphamab Biopharmaceuticals and 3D Medicines announce the signing of a License Agreement for KN035 (Envafolimab) for Multiple Geographies around the World
2024-01-25 18:00
Asieris will Present For the First Time Interim Analysis Data of Oral APL-1202 in Combination with PD-1 Inhibitor Tislelizumab for Neoadjuvant Treatment of Muscle-Invasive Bladder Cancer at 2024 ASCO-GU
2024-01-25 16:56
Empowering Communities - Summit Planners launches Will Planning Seminars for the members of the public.
2024-01-25 11:53
Alphamab Oncology and 3DMedicines Entered into a Licensing Agreement with Glenmark for KN035
2024-01-25 10:40
PS128 Successfully Targets Behavioral and Emotional Challenges in Autism Spectrum Disorder (ASD): Completion of Pivotal Clinical Trial on Preschool Children with ASD
2024-01-25 10:00
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect
2024-01-25 08:30
icotec ag raises $30m in growth financing from MVM Partners
2024-01-25 01:45
FDA purchases digiM I2S software for the assessment of product quality attributes
2024-01-24 23:37
ŸNSECT GRANTED FIRST APPROVAL OF ITS KIND, TO COMMERCIALISE MEALWORM PROTEINS FOR DOG FOOD IN THE USA
2024-01-24 22:09
Wellysis Goes Global with ECG Monitor 'S-Patch', Enters US and Indian Markets
2024-01-24 22:00
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit
2024-01-24 21:32
Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy
2024-01-24 21:30
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI
2024-01-24 21:00
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases'
2024-01-24 20:00
SHL Medical partners with SteriPack Group to set up final assembly service
2024-01-24 18:00
1
137
138
139
140
141
1599